Skip to main content
ACT $49.94 +0.32%
ACT logo

ACT · Enact Holdings, Inc.

Track ACT — free
$49.94 +0.16 (+0.32%) At close · Aug 14
Market Cap
$6.86B
Shares
137.48M
All earnings calls

Earnings call · FY2025 Q3

Enact Holdings, Inc. Q3 FY2025 Earnings Call

Enact Holdings, Inc. Q3 FY2025 Earnings Call

Concluded Nov 6, 2025
Nov 6, 2025 22 turns
Period
FY2025 Q3
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Credit Performance 21 Capital Return 18 Expense Management 16 New Insurance Written / Originations 15 Capital & Balance Sheet Strength 13 Macroeconomic Environment 10

Management tone

Confident

Net tone +72 · low hedging

Grounding quotes
  • “we are pleased to announce our updated 2025 capital return expectation of approximately $500 million, up from prior guidance of $400 million”
  • “Our results demonstrate the strength of our business and our ongoing commitment to creating long-term value for our shareholders”
  • “Credit performance continues to be strong, and we remain well reserved for a range of scenarios”
  • “we operate in an uncertain environment. So we always keep that in mind”

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $311.45M +0.6% YoY
Diluted EPS $1.10 -4.3% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Nov 5, 2025.

Metric Guided
Total 2025 capital return
total 2025
$500M

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Capital return
2025
$500M

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Buybacks · derived
$105.51M
Shares repurchased
2.82M
Dividend / share
$0.21
Full-screen source Call document